Abeona Therapeutics Stock Forecast for 2023 - 2025 - 2030

Updated on 04/25/2024

Stock Rating
8
Price Target
$17.00
Consensus
Outperform
Upside
432.92%
Analysts
2
Stock Rating
8
Upside
432.92%
Analysts
2
Price Target
$17.00

Abeona Therapeutics Stock Forecast and Price Target

If Abeona Therapeutics's stock price reached the average yearlong target of $17.00 given by two well-known analysts in recent months, there would be a potential upside of approximately 432.92% from its last closing price in April, 2024. This potential increase is based on a high estimate of $36.00 and a low estimate of $12.00. If you are not interested in ABEO stock, you may still be interested in its competitors and their current standings.

$17.00

432.92% Upside

Buy
Buy

Abeona Therapeutics Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Abeona Therapeutics's Price has grown, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $3.43 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
$3.43
2025 Fair Value Forecast
$3.82
2026 Fair Value Forecast
$4.24
2027 Fair Value Forecast
$4.72
2028 Fair Value Forecast
$5.25
2029 Fair Value Forecast
$5.83
2030 Fair Value Forecast
$6.49

Abeona Therapeutics Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Abeona Therapeutics's Revenue has decreased from $10.00M to $1.41M – a 85.90% drop! In the next year, analysts believe that Revenue will reach $13.57M – an increase of 862.41%. For the next seven years, the forecast is for Revenue to grow by 21839.72%.

2024 Rev Forecast
$0.01B
2025 Rev Forecast
$0.06B
2026 Rev Forecast
$0.15B
2027 Rev Forecast
$0.25B
2028 Rev Forecast
$0.29B
2029 Rev Forecast
$0.29B
2030 Rev Forecast
$0.31B

Abeona Therapeutics Dividend per Share Forecast for 2023 - 2025 - 2030

Abeona Therapeutics Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$-22000000.00
2025 FCF Forecast
$0.01B
2026 FCF Forecast
$0.09B
2027 FCF Forecast
$0.21B
2028 FCF Forecast
$0.20B
2029 FCF Forecast
$0.18B
2030 FCF Forecast
$0.17B

Abeona Therapeutics EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Abeona Therapeutics's EBITDA has grown by 1.75%, rising from $-43.92M to $-44.69M. For the next year, analysts predict that EBITDA will reach $-47.61M – an increase of 6.53%. Over the next eight years, experts believe that Abeona Therapeutics's EBITDA will grow at a rate of 6.93%.

2023 EBITDA Forecast
$-47609746.67
2024 EBITDA Forecast
$-46852751.69
2025 EBITDA Forecast
$-48997045.96
2026 EBITDA Forecast
$-47545100.17
2027 EBITDA Forecast
$-47591060.43
2028 EBITDA Forecast
$-47364209.71
2029 EBITDA Forecast
$-47905740.51
2030 EBITDA Forecast
$-47785976.16

Abeona Therapeutics EBIT Forecast for 2023 - 2025 - 2030

Abeona Therapeutics's EBIT has decreased In the last two years, from $-48.50M to $-45.26M – a 6.68% drop. In the next year, analysts predict that EBIT will jump to $-46.23M – up 2.14% from the current level. In 2030, professionals predict that Abeona Therapeutics's EBIT will decrease by 454.62%, to $160.50M.

2024 EBIT Forecast
$-46230000.00
2025 EBIT Forecast
$-11560000.00
2026 EBIT Forecast
$0.06B
2027 EBIT Forecast
$0.12B
2028 EBIT Forecast
$0.15B
2029 EBIT Forecast
$0.14B
2030 EBIT Forecast
$0.16B

Abeona Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Abeona Therapeutics's EPS has grown, rising from $-22.75 to $0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach $-1.77 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
$-1.77
2025 EPS Forecast
$-0.47
2026 EPS Forecast
$1.63
2027 EPS Forecast
$4.30
2028 EPS Forecast
$4.23
2029 EPS Forecast
$4.02
2030 EPS Forecast
$4.34